PE20040526A1 - Amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos - Google Patents

Amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos

Info

Publication number
PE20040526A1
PE20040526A1 PE2003000514A PE2003000514A PE20040526A1 PE 20040526 A1 PE20040526 A1 PE 20040526A1 PE 2003000514 A PE2003000514 A PE 2003000514A PE 2003000514 A PE2003000514 A PE 2003000514A PE 20040526 A1 PE20040526 A1 PE 20040526A1
Authority
PE
Peru
Prior art keywords
azaindol
metilen
piperidin
phenyl
alkyl
Prior art date
Application number
PE2003000514A
Other languages
English (en)
Spanish (es)
Inventor
Tao Wang
Zhongxing Zhang
Kap-Sun Yeung
Nicholas A Meanwell
Carol Bachand
Daniel H Deon
Edward H Ruediger
Clint A James
Zhilei Qiu
Zhiwei Yin
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32312411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20040526(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20040526A1 publication Critical patent/PE20040526A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE2003000514A 2002-05-28 2003-05-28 Amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos PE20040526A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38350902P 2002-05-28 2002-05-28

Publications (1)

Publication Number Publication Date
PE20040526A1 true PE20040526A1 (es) 2004-08-28

Family

ID=32312411

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000514A PE20040526A1 (es) 2002-05-28 2003-05-28 Amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos

Country Status (31)

Country Link
US (1) US20040063744A1 (enExample)
EP (1) EP1513832B1 (enExample)
JP (1) JP4446889B2 (enExample)
KR (1) KR101001811B1 (enExample)
CN (1) CN100528866C (enExample)
AR (1) AR040230A1 (enExample)
AU (1) AU2003301958B2 (enExample)
BR (2) BR0311541A (enExample)
CA (1) CA2487542C (enExample)
CL (1) CL2003001087A1 (enExample)
CO (1) CO5631440A2 (enExample)
DK (1) DK1513832T3 (enExample)
ES (1) ES2460728T3 (enExample)
GE (1) GEP20074152B (enExample)
HR (1) HRP20041137B1 (enExample)
IL (1) IL165200A (enExample)
IS (1) IS2945B (enExample)
MX (1) MXPA04011670A (enExample)
MY (1) MY139058A (enExample)
NO (1) NO329691B1 (enExample)
NZ (1) NZ536661A (enExample)
PE (1) PE20040526A1 (enExample)
PL (1) PL216388B1 (enExample)
PT (1) PT1513832E (enExample)
RS (1) RS53021B (enExample)
RU (1) RU2323934C2 (enExample)
SI (1) SI1513832T1 (enExample)
TW (1) TWI310381B (enExample)
UA (1) UA79470C2 (enExample)
WO (1) WO2004043337A2 (enExample)
ZA (1) ZA200409504B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20050075364A1 (en) * 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
US7087610B2 (en) * 2004-06-03 2006-08-08 Bristol-Myers Squibb Company Benzothiazole antiviral agents
WO2005121140A1 (en) 2004-06-09 2005-12-22 Glaxo Group Limited Pyrrolopyridine derivatives
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
MX2008001935A (es) * 2005-08-09 2008-03-26 Glaxo Group Ltd Derivados de imidazopiridina como ligandos del receptor de canabinoides.
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
US7504399B2 (en) * 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
WO2008145616A1 (en) * 2007-05-25 2008-12-04 Abbott Gmbh & Co. Kg Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
WO2009011912A1 (en) * 2007-07-18 2009-01-22 Bristol-Myers Squibb Company A composition for treating hiv comprising virus-like particles
CN102131810B (zh) * 2008-06-25 2014-02-26 百时美施贵宝公司 作为抗hiv剂的二酮稠合的吡咯并哌啶类和吡咯并哌嗪类
ES2389478T3 (es) * 2008-06-25 2012-10-26 Bristol-Myers Squibb Company Derivados de dicetopiperidina como inhibidores de la fijación del VIH
JP5638527B2 (ja) * 2008-09-04 2014-12-10 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Hiv結合阻害剤の最適な送達のための安定な医薬組成物
KR20110136819A (ko) * 2009-02-27 2011-12-21 시가 테크놀로지스, 인크. 뎅기 바이러스 감염의 치료 및 예방을 위한 티에노피리딘 유도체
WO2010114181A1 (en) 2009-04-02 2010-10-07 Shionogi & Co., Ltd. Acrylamide compounds and the use thereof
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
US8450361B2 (en) * 2010-08-06 2013-05-28 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
US8912195B2 (en) 2010-12-02 2014-12-16 Bristol-Myers Squibb Company Alkyl amides as HIV attachment inhibitors
EP2696937B1 (en) 2011-04-12 2017-05-17 VIIV Healthcare UK (No.5) Limited Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
EP2751118B1 (en) 2011-08-29 2016-10-12 Bristol-Myers Squibb Company Spiro bicyclic diamine derivatives as hiv attachment inhibitors
WO2013033061A1 (en) 2011-08-29 2013-03-07 Bristol-Myers Squibb Company Fused bicyclic diamine derivatives as hiv attachment inhibitors
US8889869B2 (en) * 2012-02-08 2014-11-18 Bristol-Myers Squibb Company Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
WO2013138436A1 (en) 2012-03-14 2013-09-19 Bristol-Myers Squibb Company Cyclolic hydrazine derivatives as hiv attachment inhibitors
US9655888B2 (en) * 2012-08-09 2017-05-23 VIIV Healthcare UK (No.5) Limited Tricyclic alkene derivatives as HIV attachment inhibitors
EP2895471B1 (en) * 2012-08-09 2016-11-23 VIIV Healthcare UK (No.5) Limited Piperidine amide derivatives as hiv attachment inhibitors
WO2017112576A1 (en) * 2015-12-21 2017-06-29 Dow Global Technologies Llc Methods for external base-free suzuki couplings
CN108059611A (zh) * 2018-01-22 2018-05-22 济南舜景医药科技有限公司 一种用于治疗心率不齐药物中间体的合成方法
CN109053575A (zh) * 2018-08-24 2018-12-21 遵义医学院 3-环丙基-1-甲基-1h-吡唑-4-甲醛的制备工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023265A (en) * 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
US5124327A (en) * 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5424329A (en) * 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
JP2002515891A (ja) * 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物
US6469006B1 (en) * 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20020061892A1 (en) * 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6573262B2 (en) * 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives

Also Published As

Publication number Publication date
KR101001811B1 (ko) 2010-12-15
PL216388B1 (pl) 2014-03-31
TWI310381B (en) 2009-06-01
CA2487542A1 (en) 2004-05-27
JP2006507326A (ja) 2006-03-02
IS2945B (is) 2016-05-15
CL2003001087A1 (es) 2005-02-11
WO2004043337A3 (en) 2004-11-11
TW200406397A (en) 2004-05-01
BR0311541A (pt) 2006-06-06
BRPI0311541B1 (pt) 2018-04-24
GEP20074152B (en) 2007-07-10
SI1513832T1 (sl) 2014-04-30
PT1513832E (pt) 2014-05-22
AR040230A1 (es) 2005-03-23
RU2323934C2 (ru) 2008-05-10
MXPA04011670A (es) 2005-03-07
AU2003301958B2 (en) 2009-10-01
CA2487542C (en) 2011-09-27
RS101304A (sr) 2006-10-27
WO2004043337A2 (en) 2004-05-27
UA79470C2 (en) 2007-06-25
CO5631440A2 (es) 2006-04-28
RU2004138565A (ru) 2005-07-20
IL165200A (en) 2011-01-31
IL165200A0 (en) 2005-12-18
ZA200409504B (en) 2006-05-31
HRP20041137B1 (hr) 2014-11-21
EP1513832B1 (en) 2014-03-05
IS7546A (is) 2004-11-22
EP1513832A4 (en) 2010-03-10
AU2003301958A1 (en) 2004-06-03
HRP20041137A2 (en) 2005-06-30
NZ536661A (en) 2007-12-21
PL373603A1 (en) 2005-09-05
ES2460728T3 (es) 2014-05-14
CN100528866C (zh) 2009-08-19
JP4446889B2 (ja) 2010-04-07
CN1671697A (zh) 2005-09-21
MY139058A (en) 2009-08-28
KR20050013558A (ko) 2005-02-04
NO329691B1 (no) 2010-11-29
NO20045064L (no) 2005-02-23
EP1513832A2 (en) 2005-03-16
US20040063744A1 (en) 2004-04-01
DK1513832T3 (da) 2014-05-26
RS53021B (sr) 2014-04-30

Similar Documents

Publication Publication Date Title
PE20040526A1 (es) Amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos
NO20044807L (no) Heratitt C virus inhibitorer
LU91069I2 (fr) Aprepitant et ses sels pharmaceutiquement acceptables (EMEND)
PE20080952A1 (es) Amidas azociclicas fungicidas
PE20050020A1 (es) DERIVADOS 4-(2-OXO-2,3-DIHIDRO-1-H-IMIDAZO[4,5-b]PIRIDIN-1-IL)-N-(2-OXO-AZEPAN-3-IL)PIPERIDINIL-1-CARBOXAMIDA SUSTITUIDOS COMO ANTAGONISTAS DEL RECEPTOR CGRP
PE20001419A1 (es) COMPLEJO DEL INHIBIDOR DE RAS-FARNESILTRANSFERASA Y SULFOBUTILETER-7-ß-CICLODEXTRINA O 2-HIDROXIPROPIL-ß-CICLODEXTRINA Y METODO
CO5320599A1 (es) Inhibidores no peptidilicos de la union a las celulas depen dientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
NO20062267L (no) Hepatitt C virus inhibitorer
PE2799A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
AR051682A1 (es) Dispositivo optoelectronico fotosensible organico que posee una capa bloqueadora del exciton de fenantrolina
PE20090444A1 (es) Eteres heterociclicos sustituidos y su uso en trastornos del snc
DE3868301D1 (de) 2-(methyl(4-piperidinyl))-1,2,3,4-tetrahydro-9h-pyrido(3,4-b)indolderivate, ihre herstellung und therapeutische verwendung.
PE16399A1 (es) Compuestos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores
UY25904A1 (es) Sulfonamidas heterocíclicas inhibidoras de receptores de endotelina
MA23745A1 (fr) Procede pour la preparation de nouveaux sulfonamides
UA27467C2 (uk) ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
CO5050296A1 (es) Derivados de 1-arenosulfonil-2-arilo-pirrolidina y de piperidina
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
PE20071161A1 (es) Derivados de urea sustituidos como moduladores del sarcomero cardiaco
PE20060481A1 (es) N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas
PE20060770A1 (es) Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1
EA200200727A1 (ru) Новые производные индола
AP2004003084A0 (en) 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
NO955176D0 (no) Benzenderivat nyttig for ischemiske sykdommer
PE16499A1 (es) Compuestos heterociclicos de guanidinilamino utiles como agonistas de alfa-2 adrenoreceptores

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed